Subscribe to RSS Feed
Tough decision for Roche following mixed Phase II Trial results for Alzheimer’s drug, says GlobalData Analyst
UK, 24 Jul 2014 /- GlobalData
• Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials
23nd Meeting of the European Neurological Society 8–11 June, 2013, Barcelona/Spain
Switzerland, 15 Mar 2013 /- European Neurological Society (ENS)
Dear Ladies and Gentlemen,
Highlights of the 25th Congress of the European College of Neuropsychopharmacology (ECNP) 2012
The Netherlands, 25 Oct 2012 /- European College of Neuropsychopharmacology (ECNP)
Europe’s leading voice for research on disorders of the brain: celebrating a quarter-century at the cutting edge
Suicide in children and adolescents
The Netherlands, 14 Oct 2012 /- European College of Neuropsychopharmacology (ECNP)
Europe’s leading voice for research on disorders of the brain celebrates its 25-year anniversary
ENS Congress: International study: strokes among young people often overlooked
Switzerland, 12 Jun 2012 /- European Neurological Society (ENS)
ENS 2012: 3,000 neurologists meet in Prague
People living with Multiple Sclerosis (MS) face huge inequalities in access, quality and cost of care across Europe
Belgium, 24 Apr 2012 /- European Multiple Sclerosis Platform (EMSP)
Brussels, 24 April 2012 – Growing disparities in Multiple Sclerosis (MS) care across Europe were highlighted today in the European Parliament, by Romanian MEP...
Unlocking Autism's Mysteries: New Brain Imaging and Computer Modelling used To Predict Autistic Brain Activity and Behaviour
USA, 07 Mar 2012 /- Carnegie Mellon University
Predictions Will Provide Scientists With Clear Targets for Autism Intervention and Treatment Therapies.
Treat insomnia early to reduce risk of developing other illnesses
Canada, 18 Jan 2012 /- Université Laval
Insomnia is the most common sleep disorder, but despite advances in diagnosis and management it often goes unrecognised and untreated. Left untreated, insomnia...
Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defects
UK, 24 May 2011 /- ICR (UK) Publishing
Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defects
Use of newer-generation antiepileptic drugs, which are also prescribed for bipolar mood disorders and migraine headaches, during the first trimester of...